Onkos Surgical wins FDA de novo nod for antibacterial-coated orthopedic implants
April 9, 2024
Onkos Surgical this week announced it received FDA de novo approval for its antibacterial coated implants.
Onkos Surgical this week announced it received FDA de novo approval for its antibacterial coated implants.
Vivos Therapeutics specializes in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) in adults).
Medical Microinstruments said the system could increase the number of physicians who can perform complicated microsurgical procedures.